281 related articles for article (PubMed ID: 25971324)
1. Evaluation of the Efficacy of Novel Oxazolidinone Analogues against Nontuberculous Mycobacteria In Vitro.
Zhao W; Jiang Y; Bao P; Li Y; Tang L; Zhou Y; Zhao Y
Jpn J Infect Dis; 2015; 68(6):520-2. PubMed ID: 25971324
[TBL] [Abstract][Full Text] [Related]
2.
Kim DH; Kim SY; Koh WJ; Jhun BW
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0230620. PubMed ID: 33903101
[TBL] [Abstract][Full Text] [Related]
3.
Brown-Elliott BA; Wallace RJ
J Clin Microbiol; 2017 Jun; 55(6):1747-1754. PubMed ID: 28330892
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria.
Brown-Elliott BA; Crist CJ; Mann LB; Wilson RW; Wallace RJ
Antimicrob Agents Chemother; 2003 May; 47(5):1736-8. PubMed ID: 12709349
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.
Rodriguez Díaz JC; López M; Ruiz M; Royo G
Int J Antimicrob Agents; 2003 Jun; 21(6):585-8. PubMed ID: 12791475
[TBL] [Abstract][Full Text] [Related]
8. Activities of Linezolid against nontuberculous mycobacteria.
Cavusoglu C; Soyler I; Akinci P
New Microbiol; 2007 Oct; 30(4):411-4. PubMed ID: 18080676
[TBL] [Abstract][Full Text] [Related]
9. Activities of linezolid against rapidly growing mycobacteria.
Wallace RJ; Brown-Elliott BA; Ward SC; Crist CJ; Mann LB; Wilson RW
Antimicrob Agents Chemother; 2001 Mar; 45(3):764-7. PubMed ID: 11181357
[TBL] [Abstract][Full Text] [Related]
10. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece.
Gitti Z; Mantadakis E; Maraki S; Samonis G
Future Microbiol; 2011 Sep; 6(9):1099-109. PubMed ID: 21958147
[TBL] [Abstract][Full Text] [Related]
13.
Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
[TBL] [Abstract][Full Text] [Related]
14.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
15.
Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
[TBL] [Abstract][Full Text] [Related]
16. In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria.
Molicotti P; Ortu S; Bua A; Cannas S; Sechi LA; Zanetti S
New Microbiol; 2006 Oct; 29(4):275-80. PubMed ID: 17201094
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
Hershko Y; Adler A
Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
[TBL] [Abstract][Full Text] [Related]
19. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
[TBL] [Abstract][Full Text] [Related]
20. Sudapyridine (WX-081) antibacterial activity against
Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
